9RF5
M. tuberculosis meets European Lead Factory: identification and structural characterization of novel Rv0183 inhibitors using X-ray crystallography: ELF8
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PETRA III, DESY BEAMLINE P11 |
Synchrotron site | PETRA III, DESY |
Beamline | P11 |
Temperature [K] | 100 |
Detector technology | PIXEL |
Collection date | 2022-11-22 |
Detector | DECTRIS EIGER2 X 16M |
Wavelength(s) | 1.033230 |
Spacegroup name | P 21 21 2 |
Unit cell lengths | 82.687, 91.104, 40.426 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 37.650 - 1.800 |
R-factor | 0.1679 |
Rwork | 0.166 |
R-free | 0.20160 |
Structure solution method | MOLECULAR REPLACEMENT |
RMSD bond length | 0.007 |
RMSD bond angle | 0.918 |
Data reduction software | XDS |
Data scaling software | Aimless |
Phasing software | PHASER |
Refinement software | PHENIX ((1.20.1_4487: ???)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 37.650 | 1.864 |
High resolution limit [Å] | 1.800 | 1.800 |
Rmerge | 0.019 | |
Number of reflections | 29055 | 2845 |
<I/σ(I)> | 19.7 | |
Completeness [%] | 99.8 | |
Redundancy | 2 | |
CC(1/2) | 0.999 | 0.959 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, SITTING DROP | 7.5 | 293.15 | PEG 1000, PEG 3350, MPD, HEPES, MOPS, CHAPS, CHAPSO, Sodium glycocholate hydrate, Taurocholic acid sodium salt hydrate |